Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Rivian Automotive, Inc. (RIVN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Rivian Automotive, Inc. — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while Rivian Automotive, Inc. trades at $14.34 (market cap $20.76B). The key difference: Rivian Automotive, Inc. is far larger — about 12.1× Nuvation Bio Inc. Class A Common Stock's market cap, and Rivian Automotive, Inc. is more actively traded (21,976,075 versus 5,448,712). Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Rivian Automotive, Inc. for 61 Days on average.
| NUVB | RIVN | |
|---|---|---|
Market Cap | $1.71B | $20.76B |
Volume | 5,448,712 | 21,976,075 |
Sector | Health | Consumer Cyclical |
52-Week High | $9.54 | $22.45 |
52-Week Low | $3.41 | $12.50 |
Typical Hold Time | 0 Days | 61 Days |
Enterprise Value | $1.30B | $20.81B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Rivian (RIVN) trades at $14.33, down 1.24% on the day, amid bearish technical signals and ongoing financial losses. The company reported record Q3 2026 deliveries of 19,248 vehicles, beating estimates, but maintained its full-year guidance, disappointing investors seeking an upward revision. Revenue growth is improving, with 2025 revenue at $5.39 billion, yet net losses remain substantial at -$3.65 billion, reflecting high costs and scaling challenges in the competitive EV market.
The outlook is mixed: strong delivery growth and analyst buy ratings (48%) suggest potential, but persistent cash burn, negative margins, and technical bearishness pose significant risks. Investors should weigh the company's progress in scaling production and autonomy technology against its hefty losses and competitive pressures in the evolving electric vehicle industry.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Rivian Automotive, Inc.
Rivian Automotive, Inc. is an automotive technology company. The Company designs and manufactures vans, trucks, and sports utility vehicles, as well as offers repair and maintenance services. Rivian Automotive serves customers in North America and the United Kingdom.
Read more on RIVN →
